Status:
COMPLETED
Tahiti-families: Polynesian Families of Gout Patients
Lead Sponsor:
Lille Catholic University
Collaborating Sponsors:
Variant Bio, Inc.
University of Birmingham
Conditions:
Gout
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Gout is a chronic disease caused by the deposit of monosodium urate (MSU) crystals in body tissues secondary to hyperuricemia. Patients with gout suffer severe attacks of acute joint pain. As the dise...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- Case group :
- Gout patients
- Polynesian origin
- Aged 18 to 80 years
- Agreeing to participate in the study
- Having a 1st or 2nd degree relative who is also gouty and a 1st degree relative of the same generation and sex who is not gouty
- Control group :
- Non-gouty individuals who are 1st degree relatives of a gouty patient of the same generation and sex
- Aged 18 to 80 years
- Agreeing to participate in the study
- Exclusion Criteria :
- Pregnant women
- Persons under guardianship, curatorship or other legal incapacity
- Persons with a contraindication to Magnetic resonance imaging (MRI) examination
- For non-gouty controls : current hyperuricemic treatment (Allopurinol, Febuxostat, Probenecid or Benzbromarone)
- For gouty case : not participating in the TOPATA study (NCT04812886)
Exclusion
Key Trial Info
Start Date :
May 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04900090
Start Date
May 25 2021
End Date
August 31 2021
Last Update
March 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Polynésie Française
Papeete, Ville de Pirae, French Polynesia, 98713